Koumpis, Epameinondas
Minga, Eva
Talimtzi, Persefoni
Angelopoulou, Maria
Chatzileontiadou, Sofia
Dimou, Maria
Besikli-Dimou, Sotiria
Efstathopoulou, Maria
Gogos, Dimitris
Hatjiharissi, Evdoxia
Hatzimichael, Eleftheria
Iskas, Michail
Konstantinou, Eliana
Kotsianidis, Ioannis
Machairas, Alexandros
Mpalaoura, Eugenia
Mpanti, Anastasia
Panagiotidis, Panagiotis
Pangalis, Gerasimos
Papadopoulos, Ioannis
Papaioannou, Maria
Siakantaris, Marina
Stavroyianni, Niki
Vassilakopoulos, Theodoros
Vrachiolias, George
Stamatopoulos, Kostas
Chatzidimitriou, Anastasia
Chatzikonstantinou, Thomas
Funding for this research was provided by:
Centre for Research & Technology Hellas
Article History
Received: 26 April 2026
Accepted: 29 June 2026
First Online: 3 July 2026
Declarations
: All human participants included in this study provided informed consent prior to their participation.The study has been approved by the ethics and research integrity committee of the Centre for Research and Technology Hellas.
: Eleftheria Hatzimichael received honoraria from AbbVie, AstraZeneca, Bristol Myers Squibb, Janssen, Lilly and Swixx BioPharma. Kostas Stamatopoulos received research support from AbbVie, AstraZeneca, Janssen, Novartis, and Roche; honoraria from AbbVie, AstraZeneca, Bristol Myers Squibb, Janssen and Lilly. Thomas Chatzikonstantinou received honoraria from AbbVie, AstraZeneca, and BeOne. No other potential competing interests were reported.
: The study supporters did not have access to the data and were not involved in the study design, collection, analysis, or interpretation of the data, the writing of the article, and the decision to submit it for publication.